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1. INTRODUCTION 
The branched chain 2-oxoacid dehydrogenase 
complexes of ox kidney [ 11, rat heart, kidney and 
liver [2-61 and rabbit liver [7] are inactivated by 
phosphorylation with ATPMg and some aspects of 
the regulation of the kinase reaction have been de- 
scribed [S]. Little is known of reactivation of phos- 
phorylated complex, although its occurrence in mi- 
tochondria is documented 12-41. We show here 
that phosphorylated ox kidney BCDH complex is 
activated without dephosphorylation by a high 
speed supernatant fraction prepared from extracts 
of rat liver or kidney mitochondria. Activator was 
not detected in a similar fraction of rat heart mito- 
chondria. Activator was thermolabile, non-diffusi- 
ble by dialysis, inactivated by trypsin and precipi- 
tated by (NI&hS04. 
complex were omitted, in order to increase the 
yield of BCDH complex (S-IO-fold) and the rate 
of inactivation by MgATP ( -4-fold). Apparent 
first order rate constants for inactivation by 
MgATP ranged from l-3. Activity of pyruvate de- 
hydrogenase complex was up to 80% of that of 
BCDH complex as estimated by the activity ratio 
with ketoleucine and pyruvate [I]. Pig heart pyru- 
vate dehydrogenase complex was purified as in [9]. 
2. EXPERIMENTAL 
Sources of chemicals, biochemicals, and [y-32P]- 
ATP were as in [l]. BCDH complex was purified 
partially from ox kidney mitochondria. The pro- 
cedure was as in [ 1] incorporating the modification 
given in [8]. The final two steps in [1] (precipita- 
tions at pH 6.8 and 6.4) which complete separation 
of BCDH complex from pyruvate dehydrogenase 
Abbreviations: BCDH complex, branched chain 2-0x0- 
acid dehydrogenase complex; DTT, dithiothreitol; 
EGTA, ethanedioxybis(ethylamine)tetraacetate; HSS, 
high-speed supernatant fraction; ketoleucine, 4-methyl 
2-oxopentanoate; SDS-PAGE, sodium dodecyl sul- 
phate-polyacrylamide gel electrophoresis 
Mitochondria were prepared from rat heart as in 
[lo], from rat liver and kidney as in [6] and from 
rat skeletal muscles with trypsin as in [ll]. For 
preparation of HSS mitochondrial pellets were 
frozen (liquid N2), thawed, and dispersed into ex- 
traction buffer (30 mM potassium phosphate/ 
5 mM DTT/S mM EGTA/l% (v/v) ox serum 
(pH 7.5); in some experiments 0.2 mM TPP). Pro- 
tein (estimated as in [ 121 was adjusted to 50 mg/ml 
(exclusive of ox serum protein) by dilution with 
extraction buffer. After freezing and thawing X2 
extracts were centrifuged for 90 min at 150 000 x g. 
The supernatant was removed and, where neces- 
sary, stored at -10°C. Dialysis where performed, 
was against 100 vol. extraction buffer (without 
TPP) at 0°C for 24 h. For assay of BCDH complex 
and phosphorylated BCDH complex heart mito- 
chondria were incubated for 10 min at 30°C in 
KC1 medium [ 131 (2 mg mitochondrial protein/ 
ml), separated by centrifugation as in [13], frozen 
in liquid N2 an&“extracts prepared as above. For 
preparation of extracts containing BCDH mito- 
chondria were incubated without respiratory sub- 
strate. For preparation of extracts containing phos- 
phorylated BCDH incubations were in 5 mM 
2-oxoglutarate/0.5 mM L-malate. 
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Phosphorylated ox kidney BCDH complex was 
prepared by incubation of BCDH complex 
(1 unit/ml) for 5 min at 30°C with 0.3-0.5 mM 
ATP in 30 mM potassium phosphate/5 mM DTT/ 
5 mM EGTA/ 10 mM MgCl2/1% (v/v) ox serum 
(pH 7.5). This resulted in 296% inactivation of 
BCDH complex by phosphorylation. Preparations 
were used’ either without further treatment 
(method A) or freed of adenine nucleotides and 
(where present) 32Pi by dialysis followed by sedi- 
mentation of the complex through a 2% (w/v) 
sucrose layer (150 000 xg, 90 min) (method B); or 
by sedimentation without dialysis (method C). Di- 
alysis resulted in some reactivation and de- 
phosphorylation (up to 30%); sedimentation gave 
no reactivation of dephosphorylation. Phosphoryl- 
ated pig heart pyruvate dehydrogenase complex 
was prepared by method A. 
Rat heart BCDH complex was assayed spectro- 
photometrically by the initial rate of NADH for- 
mation with ketoleucine as substrate as in [6] (but 
with 30 units/ml lipoamide dehydrogenase). Ox 
kidney BCDH complex was assayed by the same 
method omitting Triton. Pyruvate dehydrogenase 
complex was assayed with 1 mM pyruvate in place 
of ketoleucine. In the presence of rat liver HSS 
(which contains lactate dehydrogenase) pyruvate 
dehydrogenase complex was assayed by coupling 
to arylamine acetyltransferase as in [ 121. Assays of 
32P in phosphorylated complexes and of “Pi, and 
SDS-PAGE and autoradiography were by meth- 
ods given in [1,6,13]. 
One unit of enzyme activity forms 1 pmol sub- 
strate/min (NADH or acetylCoA) at 30°C. Values 
for K, and V,,, were computed as in [ 141. (K, is the 
concentration of HSS giving half-maximal reac- 
tivation of phosphorylated BCDH complex.) In 
what follows results are given as mean + SEM; 
and HSS concentrations are given as mg mito- 
chondrial protein from which they were made. 
3. RESULTS AND DISCUSSION 
3.1. Specificity of assays 
Pyruvate dehydrogenase complex (present in 
BCDH complex used here) does not oxidize keto- 
leucine and does not interfere with the assay of 
BCDH complex. On incubation with ATP the 2 
complexes were phosphorylated and inactivated 
concomitantly; with [$2P]ATP in experiments to 
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Fig.1. Effect of mitochondrial high-speed supernatant 
fraction (HSS) on the activity of phosphorylated ox 
kidney BCDH complex. Taken from the chart of a 
Gilford recording spectrophotometer omitting excur- 
sions due to absorbance of HSS and subsequent backing 
off. The cuvette contained in 1.4 ml, substrates, co- 
enzymes and phosphorylated complex prepared by 
method C (equivalent to 20 munits BCDH complex). 
Rat heart HSS and dialysed rat liver HSS (50 ~1 equiv- 
alent to 2.5 mg mitochondrial protein) were added as 
shown. Neither HSS gave a measurable rate in the ab- 
sence of phosphorylated complex (not shown). 
be described, incorporation of 32P into the pyru- 
vate dehydrogenase complex was -30% of the 
total incorporation (SDS-PAGE and autoradio- 
graphy). Under conditions of incubation used 
phosphorylated pyruvate dehydrogenase complex 
was neither reactivated nor dephosphorylated (not 
given). 
3.2. Activation of phosphorylated BCDH complex 
by mitochondrial HSS 
Addition of rat liver mitochondrial HSS to a 
cuvette, in which phosphorylated ox kidney 
BCDH complex showed no detectable activity, led 
within seconds to substantial reactivation of phos- 
phorylated complex (fig.1). The rat liver HSS gave 
no measurable rate of NAD+ reduction in the ab- 
sence of phosphorylated complex. Reactivation 
has been observed consistently in > 100 expt with 
8 preparations of rat liver HSS and 12 prepara- 
tions of phosphorylated complex made from 3 in- 
dividual preparations of BCDH complex. Reac- 
tivation was independent of the order of addition, 
i.e., NAD+ reduction could be initiated by the 
final addition of HSS (as in fig.1) or ketoleucine or 
phosphorylated complex (not shown). all other 
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Fig.2. Effect of rat liver mitochondrial HSS on the activity of phosphorylated ox kidney BCDH complex prepared by 
method A. In all 3 panels concentrations of HSS (mg/ml) and of BCDH complex (units/l) are those in the cuvette. All 
points are means of 4 obs. (a) Double reciprocal plot showing effect of HSS concentration on activity of phosphorylated 
BCDH complex (0) or of BCDH complex (0). The activity of BCDH complex in the absence of HSS was 6.7 f 
0.11 units/l (reciprocal 0.15); that of phosphorylated BCDH complex was 0.03 f 0.008 units/l (reciprocal 33). V,,, 
values (units/l) were 8.5 1 + 0.47 (0) and 8.94 f 0.23 (o) (PC 0.001 for effect of HSS in each case; P> 0.4 for effect of 
phosphorylation in presence of HSS). The K, values (mg mitochondrial protein/ml) were 1.23 + 0.2 (0) and 0.17 + 
0.05 (o) (PcO.001 for difference). (b) Degree of activation of different concentrations of phosphorylated BCDH com- 
plex (inclusive of that present in the BCDH complex, as made) by a fixed concentration of rat liver HSS (1.77 mg/ml). 
(c) Double reciprocal plot as in (a) but with two different concentrations of phosphorylated complex (A) 5 ~1, and (A) 
10 ~1. V,,, values were 6.2 + 0.39 (5 ~1) and 10.9 f 0.28 (10 ~1) (P<O.OOl for difference); the K, values were 1.08 + 0.14 
(5 ~1) and 1.75 & 0.10 (10 ~1) (P<O.OOl for difference). 
components being present. Most preparations of 
rat liver HSS gave a blank rate in the absence of 
complex which required one or more of NAD+, 
TPP and CoA but not ketoleucine. The blank rate 
was - 1.5 nmol . min-1 . 1.77 mg mitochondrial 
protein-t . ml-l; i.e., 15% of the overall rate with 
10 munits of fully reactivated phosphorylated 
complex. The technique adopted was to measure 
the blank rate first and to initiate the BCDH com- 
plex reaction by addition of phosphorylated com- 
plex. Reactivation of phosphorylated complex was 
independent of the method of preparation (A, B or 
C); A was the method of choice because the num- 
ber of units of phosphorylated complex inactivated 
by phosphorylation is known by comparison with 
a control sample (no ATP) incubated in parallel. 
Some preparations of rat liver HSS gave near 
complete reactivation when tested at 1.77 mg/ml 
(50 ~1 in 1.4 ml in cuvette). In a typical experiment 
(4 obs.) activities with phosphorylated complex 
equivalent to 9.3 + 0.01 munits of BCDH complex 
were: 0.3 + 0.01 munits (no HSS), 10.2 + 0.05 
munits (HSS, 1.77 mg/ml, corrected for blank 
rate). Some preparations of HSS gave incomplete 
reactivation at this concentration. Fig.2(a) shows 
the extent of reactivation of phosphoryfated com- 
37 
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plex and of BCDH complex (as isolated), by dif- 
ferent concentrations of rat liver HSS (double re- 
ciprocal plot). The V, values for BCDH complex 
as isolated, and for phosphorylated complex pre- 
pared from it did not differ significantly and were 
30% greater than for unphosphorylated complex in 
the absence of HSS. This suggests that complex as 
isolated may contain - 20% of phosphorylated 
complex (values of V,,, are in legend to @2(a). 
The K, values for HSS in fig.2(a) were 1.23 mg/ 
ml (phosphorylated complex) and 0.17 mg/ml 
(complex as isolated). This suggested that the ex- 
tent of reactivation may depend upon the concen- 
tration ratio [liver HSS]/[phosphorylated com- 
plex]. This suggestion is supported by data given in 
fig2(b) in which the fractional reactivation de- 
clined as the ratio of [liver HSS]/[phosphorylated 
complex] was decreased. With 1.77 mg/ml HSS 
fractional reactivation was 63 + 1.34% at 
0.74 units/l and 39+0.95% at 14.6 units/l phos- 
phorylated complex (values inclusive of phos- 
phorylated complex in BCDH complex as made). 
In fig.2(c) is shown the effect of increasing concen- 
trations of liver HSS on the extent of reactivation 
of two concentrations of phosphorylated complex 
(5 ~1 and 10 ~1 in cuvette). The Ka value for 5 ~1 of 
phosphorylated complex was significantly less than 
that for 10 ~1 of phosphorylated complex. 
Reactivation of phosphorylated ox kidney 
BCDH complex has been shown also with HSS 
from rat and ox kidney mitochondria (not given). 
No reactivation has been seen with HSS from rat 
heart mitochondria. Fig.1 shows the results of one 
such experiment. In a more detailed study (6 obs. 
each group) activities with phosphorylated com- 
plex equivalent to 7.2 + 0.11 units/l were: phos- 
phorylated complex (no HSS) 0.28 & 0.02; phos- 
phorylated complex (heart HSS, 1.77 mg/ml) 0.14 
2 0.04; phosphorylated complex (heart and liver 
HSS, each 1.77 mg/ml) 6.3 + 0.07. This was re- 
peated with comparable results (not given). In a 
single experiment no reactivation was seen with 
HSS from rat skeletal muscle mitochondria 
(1.77 mg/ml) (not shown). 
In two separate experiments (total of 8 obs. in 
each group) rat liver HSS completely reactivated 
phosphorylated BCDH complex in extracts pre- 
pared from rat heart mitochondria incubated with 
2-oxoglutarate/L-malate; no effect was seen on 
unphosphorylated complex in extracts prepared 
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from mitochondria incubated without respiratory 
substrate (not shown). 
Phosphorylated pig heart pyruvate dehydroge- 
nase complex was not reactivated by rat liver HSS 
(not shown). 
3.3. Reactivation by rat liver HSS and protein 
bound [32P]phosphate 
Phosphorylated ox kidney BCDH complex 
(method A; 7.4 & 0.14 munits/ml in cuvette; pre- 
pared with [$*P]ATP, 1100 dpm/pmol) was as- 
sayed for active complex (4 obs.) without HSS 
(0.35 + 0.02 units/l) and with 4.43 mg/ml rat liver 
HSS (6.0 + 0.21 units/l). Protein bound [32P]phos- 
phate was assayed on triplicate samples of 50 pl 
from each cuvette. The values (corrected for 
blanks, substituting an equivalent volume of 
[Y-~~P]ATP for phosphorylated complex) were 
(12 obs.) 721 + 19 dpm (no HSS) and 733 & 
25 dpm (with HSS). This experiment shows that 
rat liver HSS does not release protein bound 
[32P]phosphate as ‘*Pi, but does not prove that 
[3*P]phosphate remained in phosphorylated 
BCDH complex. In an attempt to show this 1 ml 
samples from the cuvette were centrifuged at 
150 000 x g for 90 min to sediment phosphorylated 
complex and 50 ~1 of the supernatant assayed for 
protein bound [3*P]phosphate. The results 
(10 obs.) were 1230 + 24 dpm (no HSS; before 
sedimentation); 1218 + 15 dpm (1.77 mg/ml rat 
liver HSS; before sedimentation); 334 + 38 dpm 
(no HSS; after sedimentation); 301 2 27 dpm 
(HSS; after sedimentation). Apparently reactiva- 
tion by HSS did not diminish protein bound 3*P 
which sedimented with the phosphorylated BCDH 
and pyruvate dehydrogenase complexes. In a fur- 
ther experiment with [3*P]phosphorylated complex 
prepared by method B trichloroacetic acid-soluble 
radioactivity was measured on 1 ml from the 
cuvette. In the absence of rat liver HSS activity 
was 3.23 + 0.14 units/l and 4.8 + 0.13% of 3*P 
was trichloroacetic acid-soluble; with rat liver HSS 
activity was 11.3 ? 0.13 units/l and 3.5 + 0.07% 
of 32P was trichloroacetic acid-soluble (total 3*P 
was 920 dpm/ml). 
4. CONCLUSIONS 
Rat liver, rat kidney and ox kidney mitochon- 
dria would appear to contain a factor which reacti- 
Volume 147. number 1 FEBS LETTERS October 1982 
vates phosphorylated ox kidney BCDH complex 
without dephosphorylation. This factor appears to 
be absent from rat heart and (one experiment) rat 
skeletal muscle mitochondria. The factor has yet to 
be characterised but it is known to be inactivated 
by heat (SO’C for 10 min) and by trypsin; is non- 
diffusible by dialysis (24 h); and is precipitated by 
0.7 saturation with (NH4)2S04 with a recovery of 
-30% (not shown). This suggests that the factor 
may be a protein. 
ported by grants from the Medical Research 
Council and the British Diabetic Association. 
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